Announcements

Job offersmore »



Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




Oxford University launches MMJ research programme

Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.

The programme aims to develop new therapies for acute and chronic conditions including pain, cancer and inflammatory disease.

Through an initial investment of up to £10 million provided by Kingsley, funded through its new portfolio company Oxford Cannabinoid Technologies (OCT), and a series of research projects performed by medical research teams, Oxford will seek to identify new medical therapies through research into the molecular, cellular and systems mechanisms of cannabinoids.

Ahmed Ahmed, Professor of Gynaecological Oncology at Oxford, said: ‘Cannabinoid research has started to produce exciting biological discoveries and this research programme is a timely opportunity to increase our understanding of role of cannabinoids in health and disease. This field holds great promise for developing novel therapeutic opportunities for cancer patients.’

Associate Professor in Clinical Neurosciences, Zameel Cader said: ‘Endocannabinoid signalling is increasingly recognised as fundamentally important in the development and function of the nervous system. This exciting programme of work has the potential to lead to the development of novel therapies for neurological disorders.’

Oxford and Kingsley will host an International Cannabinoid Biomedicine Conference, designed to increase dialogue in the cannabinoid research space, the first of which will take place in Q4 2017.

Neil Mahapatra, Managing Partner of Kingsley, said: ‘Medical cannabis and cannabinoid medicine is already helping patients with some of the most distressing conditions across the world. However, research into the specific pathways and mechanisms that create this benefit is limited and long overdue. Through OCT, we hope our strategic partnership with Oxford will support the development of innovative new therapies to help millions of people around the world. The partnership gives the UK a global leadership role in this fast-growing field.’

The research programme will develop the results into innovative therapies designed to help improve the quality of life of millions of patients. Over time, OCT will fund additional cannabinoid research programmes with the University across different therapeutic areas. This strategic partnership aims to turn Oxford and OCT into a global centre of excellence in cannabinoid research.

For more information:
www.ox.ac.uk

Publication date: 3/16/2017

 


 

Other news in this sector:

12/14/2017 "New cannabis strain increases medical benefits"
12/14/2017 US (RI): Future Farm sets closing date for MMJ cultivation site
12/13/2017 Hydropothecary announces expansion plans
12/12/2017 US: As legal weed sucks up energy, an industry searches for solutions
12/11/2017 From Google to ganja
12/11/2017 US (CO): New Age Farm to acquire CBD company
12/7/2017 Canada opens consultation on proposed approach to cannabis regulation
12/6/2017 Paraguay Congress legalizes planting of medical marijuana
12/6/2017 Denmark: Orchid greenhouse to become 40,000 m2 MMJ facility
12/1/2017 US (MA): MariMed buys 70,000 sq.ft. cannabis cultivation facility
12/1/2017 Video: Aquaponic cannabis cultivation in action
11/30/2017 Swiss cannabis farm aims to supply 'legal weed' across Europe
11/29/2017 US (WA): MCOA starts construction on 30,000 sq. ft. cultivation facility
11/28/2017 Australia: The Hydroponics Company appoints CCO
11/27/2017 Canada: MMJ grower plans IPO with big warnings for investors
11/24/2017 US (MD): MariMed opens cannabis cultivation facility in Hagerstown
11/23/2017 CAN (ON): Government seeks expert advice on emerging cannabis sector
11/22/2017 US (WA): MCOA completes financing for cultivation facility
11/22/2017 "Nearly 70 percent of cannabidiol extracts sold online are mislabeled"
11/22/2017 Luxembourg moves further towards legalising medical marijuana